Clasp Therapeutics
Likely to Engage tag.Highly Engaged Employees

Business Services · Maryland, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

1450 Research Blvd 120, Rockville, Maryl...

Revenue

<$5 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
2
2
1
1
1

About Clasp Therapeutics

Clasp Therapeutics is focused on advancing immuno-oncology through the development of next-generation T cell engagers that target specific cancer mutations. Their innovative approach aims to enhance the precision of cancer treatments by enabling the immune system to identify and destroy hard-to-treat tumors. The company is dedicated to creating off-the-shelf precision immunotherapies that can be tailored to individual patients, thereby expanding treatment options for various cancer types. Clasp Therapeutics is committed to translating cutting-edge research into meaningful medicines that improve patient outcomes.Explore more
Popular SearchesClasp TherapeuticsSIC Code 87,873NAICS Code 54,541Show more

Clasp Therapeutics Org Chart

RR
United States flag for contact location.

Chief Executive Officer

PhoneEmail
James Bingham, Chief Technology Officer at Clasp Therapeutics
United States flag for contact location.

Chief Technology Officer

Flame icon indicating likelihood to engage via phone.PhoneFlame icon indicating likelihood to engage via email.Email

PhoneEmail
Get the full picture
Sign in to uncover key details.
VS
United States flag for contact location.

Chief Scientific Officer

Flame icon indicating likelihood to engage via phone.PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Clasp Therapeutics your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

Clasp Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

Clasp Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Clasp Therapeutics.

Clasp Therapeutics financials insights

Gather financial insights about Clasp Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2024

Other Financing Round

$150M

See All Clasp Therapeutics's Financials Insights

Most Recent Scoops

Project
Laboratory Operations, Medical Research, Clinical Operations
Event
Events, Engineering, Sales, Bioengineering, Laboratory Operations, Pharmaceuticals, Field /Outside Sales, Clinical Operations, Field Marketing, Operations
Person-Based
Funding
Funding
See more scoops

Top Business Services Companies

Frequently Asked Questions Regarding Clasp Therapeutics

What is Clasp Therapeutics's official website?
Clasp Therapeutics's official website is www.clasptx.com
What is Clasp Therapeutics's Revenue?
Clasp Therapeutics's revenue is <$5 Million
What is Clasp Therapeutics's SIC code?
Clasp Therapeutics's SIC: 87,873
What is Clasp Therapeutics's NAICS code?
Clasp Therapeutics's NAICS: 54,541
How many employees does Clasp Therapeutics have?
Clasp Therapeutics has 11-50 employees
What industry does Clasp Therapeutics belong to?
Clasp Therapeutics is in the industry of: Business Services, Research & Development
Who is the CTO of Clasp Therapeutics?
Clasp Therapeutics's CTO is James Bingham
What does Clasp Therapeutics do?

Clasp Therapeutics is focused on advancing immuno-oncology through the development of next-generation T cell engagers that target specific cancer mutations. Their innovative approach aims to enhance the precision of cancer treatments by enabling the immune system to identify and destroy hard-to-treat tumors. The company is dedicated to creating off... -the-shelf precision immunotherapies that can be tailored to individual patients, thereby expanding treatment options for various cancer types. Clasp Therapeutics is committed to translating cutting-edge research into meaningful medicines that improve patient outcomes.Read More

Who invested in Clasp Therapeutics?
Clasp Therapeutics has 3 investors including Catalio Capital Management, Novo Holdings and Third Rock Ventures.
Is Clasp Therapeutics a public company?
Clasp Therapeutics is private company therefore does not currently have an official ticker symbol
See more information about Clasp Therapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.